Search results

Page results

• Research seeking greater understanding of rare blood cancer and how to treat it

  A new research study at UCLH and UCL will investigate how a rare type of blood cancer develops and what types of treatment may be effective for patients.

• Second generation CAR T-cell therapy trialled in patients

  A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.

• ‘Virtual wards’ help patients to recover at home

  The UCLH@Home service is helping patients like 80-year-old Margaret Stone to continue their recovery in their own home under the care of their hospital team.

• Well done #teamUCLH on a fantastic London Landmarks Half Marathon

  Well done to everyone who ran to support UCLH in the iconic London Landmarks Half Marathon on 2 April!

• How are we doing? Parent and Patient Reported Experience Measure (PREM) survey

  The National Paediatric Diabetes Audit (NPDA) is asking all children and young people (8-19 years) and parents/carers (of children under 8 years old) who have received diabetes care in the past 6 months, to fill in the survey.

• Preterm babies do not habituate to repeated pain

  Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.

• COVID-19 NHS vaccination centre to reopen at Islington Business Design Centre

  UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.

• Mr George Attilakos

  Mr George Attilakos is a consultant in obstetrics and fetal medicine and the clinical lead for obstetrics at UCLH. Alongside managing normal pregnancies, Mr Attilakos has a special interest in the management of multiple pregnancies and high-risk pregnancies, as well as expertise in fetal medicine and fetal surgery, including in-utero treatment for congenital diaphragmatic hernia, spina bifida and twin-to-twin transfusion syndrome.

• Discontinuation of MiniMed™ Mio™ Infusion sets

  Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.

• Towards sustainable estates, facilities, technology and transport

  As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.